Introduction Cuba has emerged as a global leader in cancer immunotherapy, pioneering therapeutic vaccines, monoclonal antibodies, and interferon-based treatments. With a strong emphasis on biotechnology and medical research, Cuban scientists have developed groundbreaking therapies that improve survival rates, minimize side effects, and provide affordable cancer care. This article explores CIMAvax-EGF, Racotumomab (Vaxira), Nimotuzumab (CimaHER), Interferon...
AllCardiovascularChild DevelopmentCuba’s AchievementsCubaHeal NewsDermatologyEducationEndocrinologyGeriatricGynecologyInternational CollaborationMedical (General)NeurologyOncologyOphthalmologyOrthopedicPsychiatrySubstance Abuse RehabilitationTravel InsuranceUncategorized
Head and neck cancers encompass a range of malignancies affecting areas such as the oral cavity, pharynx, larynx, and nasal passages. These cancers pose significant health challenges worldwide, with treatments often involving surgery, radiation, and chemotherapy. In recent years, Cuba has emerged as a leader in developing innovative therapies for head and neck cancers, leveraging...
Cuba has long been recognized for its robust healthcare system and innovative medical research, particularly in oncology. The nation’s commitment to accessible healthcare and cutting-edge biotechnology has led to the development of unique cancer treatments that have garnered international attention. This article explores Cuba’s approach to cancer care, focusing on its advancements in immunotherapy, the...
Introduction Nevoid Basal Cell Carcinoma Syndrome (NBCCS), also known as Gorlin Syndrome, is a rare genetic disorder characterized by the development of multiple basal cell carcinomas (BCCs), jaw cysts, and skeletal abnormalities. Managing the numerous BCCs associated with NBCCS presents a significant clinical challenge. HeberFERON, a novel therapeutic formulation combining interferon alpha-2b and interferon gamma,...
Introduction Skin cancer is one of the most prevalent cancers worldwide, with cases continuing to rise due to increased exposure to ultraviolet (UV) radiation and other environmental factors. Among the different types of skin cancer, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common. Traditional treatments often involve surgical excision, which...
Introduction Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases, making it a significant global health concern. Traditional treatments include surgery, chemotherapy, and radiation therapy; however, these approaches often have limited efficacy, especially in advanced stages. In response to this challenge, researchers have developed Racotumomab, a therapeutic vaccine designed to...
Cimavax-EGF for Non-small Cell Lung Cancer Vaccine Cimavax-EGF is the first worldwide registered therapeutic vaccine for non-small lung cancer developed in Cuba by the Center for Molecular Immunology in conjunction with the Center for Genetic Engineering and Biotechnology. In 2008 it was approved by the Cuban regulatory authority for the use in adults with advanced...